Silexion Therapeutics Ltd... (SLXN)
NASDAQ: SLXN
· Real-Time Price · USD
7.42
0.18 (2.49%)
At close: Aug 18, 2025, 2:48 PM
Silexion Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -16.12 | -39.88 | -9.68 | -192.25 | -51.67 | -36.99 | 462.25K | 2.67K | -1.03M | 2.2K | 3.71K | 25.44K | -4.42K | -4.49K | -4.85K | -5.66K | -11.11K |
PEG Ratio | -0.44 | 0.39 | 0.00 | 1.96 | 1.80 | 0.00 | -10.1K | -533.54 | 76.88K | 31.62 | 6.39 | -216.64 | -2.15K | -610.47 | -281.27 | -58.56 | 220.39 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 43.25 | -69.87 | -100.34 | -62 | -17.49 | -16.52 | 463.97 | 68.96 | 126.68 | 37.62 | 37.79 | 37.88 | 37.90 | 37.81 | 37.74 | 37.66 | 37.60 |
P/FCF Ratio | -45.49 | -95.25 | -172.14 | -1.06K | -167.3 | -202.75 | -2.11K | -124.47K | -3.48M | 6.58K | 12.26K | -75.1K | -30.91K | -11.63K | n/a | n/a | -5.4K |
P/OCF Ratio | -45.6 | -95.25 | -173.18 | -1.06K | -167.88 | -203.4 | -2.12K | -124.45K | -3.48M | 6.58K | 12.26K | -75.1K | -30.91K | -11.63K | n/a | n/a | -5.4K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 1.35 | -1.13 | -0.94 | -0.01 | -0.01 | -0.01 | 0.79 | 0.08 | 0.06 | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 3.22 | 0.64 | 0.85 | 0.98 | 1.72 | 2.27 | 2.25 | 12.26 | 0.06 | 0.08 | 0.32 | 0.33 | 0.62 | 1.17 | 6.10 | 7.07 | 13.00 |
Current Ratio | 3.22 | 0.64 | 0.85 | 0.98 | 1.72 | 2.27 | 2.25 | 12.26 | 0.06 | 0.08 | 0.32 | 0.33 | 0.62 | 1.17 | 6.10 | 7.07 | 13.00 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -183.33 | n/a | n/a | -692.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.67 | 0.44 | 2.59 | 0.08 | 0.08 | 0.11 | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Assets | -0.21 | -0.61 | -3.84 | -0.58 | -0.4 | -0.33 | n/a | 0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Invested Capital | -0.27 | -3.79 | 30.10 | -5.16 | -0.72 | -0.53 | -0.13 | -0.01 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |